Institute for Precision Health

Research opportunities

Events

Early Career Researchers and PhD students

Join us for networking days (10 and 15 November) to generate collaborative project ideas for Precision Health research. For further information please contact Lynne Howells (lh28@le.ac.uk).

Funding

The Institute for Precision Health offers numerous funding opportunities to enhance your research and industrial collaborations via the UKRI MRC Impact Acceleration Accounts (IAA) award. Funding calls will be announced via the Institute and drugdiscovery@le.ac.uk mailbox at several points during the year. There may be further opportunity for small awards in between formal calls, so please email drugdiscovery@le.ac.uk to talk through your ideas.

Additionally, the Institute can provide funding to facilitate networking opportunities for grant development. Please contact Lynne Howells (lh28@le.ac.uk) for further information.

Postgraduate research

The Institute for Precision Health has an active postgraduate community. New studentships will be announced here, and we welcome enquiries about our PhD projects.

Our new students are undertaking world-leading research in the following areas:

Functional investigation of a potential novel drug target for progressive lung fibrosis

Developing a virtual asthma patient

Investigation of proteomic biomarkers of hypertension using microsampling-based mass spectrometry detection

  • Elliott Gyedu, supervised by Dr Pankaj Gupta and Dr Dennis Bernieh

Radiomic and multiomic investigation of molecular pathways in concentric left ventricular myocardial remodelling in Type 2 Diabetes (T2DM)

Mechanisms of intrinsic resistance to bispecific antibodies in diffuse large B cell lymphoma (DLBCL)

Understanding the effect of SGLT2i on muscle health in those with chronic disease

Further postgraduate research

2021

Targeting Mutant FBXW7 to Disable MCL1 and Induce Therapeutic Apoptosis

  • Daniel Rowell Faulkner, supervised by Professor Dean Fennell

Novel therapeutic and diagnostic approaches for EML4-ALK driven lung cancer

2020

microRNAs and fibrosis progression in asymptomatic Aortic Stenosis: towards an integrated imaging and biomarker precision medicine approach to risk stratification

Identifying mechanisms of drug resistance in endometrial cancer

2019

Using patient electronic health records to understand the interplay between disease severity, symptoms, co-morbidity and long-term health outcomes

Prediction of outcome in community acquired pneumonia admissions using Artificial Intelligence and machine learning based algorithms

  • Daniel Lozano Rojas, supervised by Dr Rob Free

The relationship between repetitive DNA and clinical radioresponse in rectal cancer

Barriers to CD19 therapy in B cell malignancies

Developing a new bioinformatics platform for integration and analysis of high throughput ‘omics data to inform drug discovery and precision medicine approaches

  • Emma Croot, supervised by Dr Athanasios Didangelos
Back to top
MENU